維生素 B2（核黃素 / Riboflavin） Vitamin B2 (Riboflavin) × 微量營養素缺乏（核黃素缺乏症 / Ariboflavinosis）
結論：證據支持
核黃素（B2）對核黃素缺乏症（ariboflavinosis）為定義性 well-established repletion，但屬於『初步至中度證據』而非 A 級：(1) 全部五個監管機構（FDA GRAS / EFSA Article 13(1) 九項生化功能宣稱 / NHS RNI / TFDA DRI / WHO RNI 1.
B 🟡 B 初步證據 已發布 🚨 high — heavy affiliate marketing in TW community
核黃素（B2）對核黃素缺乏症（ariboflavinosis）為定義性 well-established repletion，但屬於『初步至中度證據』而非 A 級：(1) 全部五個監管機構（FDA GRAS / EFSA Article 13(1) 九項生化功能宣稱 / NHS RNI / TFDA DRI / WHO RNI 1.1-1.6 mg/day）一致認定 B2 為必需水溶性維生素、RDA 明確、無 UL；(2) 學會層級 AND 與 AAFP 完全一致，臨床缺乏症狀（cheilosis / glossitis / 脂漏性皮膚炎 / normochromic-normocytic 貧血）及補充劑量（5-30 mg/day oral）皆有明確 codification；(3) L2 PubMed 五篇支持性研究（McNulty 2016 RCT n=83、Powers 2015 n=27、Nichols 2020 SR 整合 6 試驗、Suwannasom 2020 narrative review、Ward 2021 review）顯示 EGRAC 生化矯正高一致性。
降至 B 而非 A 的理由：現代 RCT 證據集中於生化終點（EGRAC）而非盲化臨床症狀終點，原始試驗多為小樣本（n=27-90）、單中心；古典 ariboflavinosis 臨床消退資料主要來自 narrative reviews 與歷史試驗，缺乏 Cochrane high-certainty MA。
L1 Examine `found_in_examine=false` 並非反證，僅反映 Examine 資料庫未將『B2 缺乏症』獨立索引為 condition（B2 本身就是該缺乏症的定義性治療）。
⚖️
評分透明度
所有分數由 7 層證據引擎計算，過程公開可查原始分數 0.66
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
B · 已發布
信心度
87%
證據方向一致性高
證據層級
E3
單篇高品質統合分析
▸查看完整決策路徑（audit trail）
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.658
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
Riboflavin Lowers Blood Pressure in Cardiovascular Disease Patients Homozygous for the 677C->T Polymorphism in MTHFR
結論：Riboflavin 1.6 mg/day significantly improved riboflavin status (EGRAC decreased from 1.42 to 1.31, p<0.001) and lowered systolic BP by 9.2 mmHg (95% CI -13.1 to -5.3) and diastolic BP by 6.0 mmHg in MTHFR 677TT homozygotes; no significant BP effect in CC or CT genotypes. Establishes that low-dose oral riboflavin reliably corrects suboptimal riboflavin status (EGRAC >1.40 indicating deficiency) within 16 weeks in adults.
前往 PubMed
Exploring trajectories in dietary adequacy of the B vitamins folate, riboflavin, vitamins B6 and B12, with advancing older age: a systematic review
結論：Subclinical riboflavin deficiency was common in older adults (EGRAC >1.40 in 27-77% across cohorts) even when intakes approximated RDA. All identified supplementation trials reported significant EGRAC reduction with doses 1.4-1.6 mg/day within 8-16 weeks, with no signal of adverse effects up to 10 mg/day. Concluded riboflavin repletion is consistently effective for biochemical deficiency, but clinical (functional) outcome data remain limited outside the MTHFR-BP literature.
前往 PubMed
Riboflavin in Human Health: A Review of Current Evidences
結論：Reaffirms that ariboflavinosis is reliably reversed by oral riboflavin at 5-30 mg/day (or 1.4-1.6 mg/day for sub-clinical deficiency) within weeks, with rapid resolution of mucocutaneous signs (cheilosis, glossitis) and normalisation of EGRAC. Notes that primary deficiency is now rare in high-income settings but persists in LMIC adolescents, pregnant/lactating women, and chronic alcohol users; emphasises riboflavin's role as cofactor for FMN/FAD-dependent reactions including folate, vitamin B6, niacin and homocysteine metabolism, so deficiency can secondarily affect those pathways.
前往 PubMed
Riboflavin deficiency, MTHFR genotype and blood pressure: current evidence and ongoing research
結論：Across four UK/Ireland RCTs, riboflavin 1.6 mg/day for 16 weeks consistently reduced EGRAC and corrected biochemical riboflavin deficiency; in MTHFR 677TT homozygotes (10-15% of European populations) this was accompanied by 5-13 mmHg reductions in SBP. Reinforces that low-dose oral riboflavin (around RDA) is sufficient to correct biochemical deficiency in adults, and that targeted repletion has a downstream clinical effect in a genetically defined subgroup.
前往 PubMed
L4a US FDA
支持
NUTRIENT SUPPLEMENT 來源↗
L4b EU EFSA
支持
a cause and effect relationship has been established between the dietary intake of riboflavin and (a) contribution to normal energy-yielding metabolism, (b) contribution to normal functioning of the nervous system, (c) maintenance of normal mucous membranes, (d) maintenance of normal red blood cells, (e) maintenance of normal skin, (f) maintenance of normal vision, (g) normal metabolism of iron… 來源↗
L4c UK NHS
謹慎
Riboflavin (vitamin B2) helps: keep skin, eyes and the nervous system healthy; the body release energy from food. ... Adults (aged 19 to 64) need about: 1.3mg a day of riboflavin for men; 1.1mg a day of riboflavin for women. You should be able to get all the riboflavin you need from your daily diet. Riboflavin cannot be stored in the body, so you need it in your diet every day. ... There's not … 來源↗
L4d TW TFDA / 衛福部
支持
維生素B2有助於維持能量正常代謝；維生素B2有助於維持皮膚的健康 來源↗
L4e WHO
支持
Riboflavin (vitamin B2) is an essential water-soluble vitamin that functions as a coenzyme in numerous redox reactions. The recommended nutrient intake for adults is 1.3 mg/day for men and 1.1 mg/day for women. 來源↗
L5a NIH Office of Dietary Supplements
支持
L5b Mayo Clinic
中性
— 本適應症無對應資料
L5c Cleveland Clinic
支持
Riboflavin prevents and treats low riboflavin levels in your body. 來源↗
L5d Harvard Health
謹慎
A biotin deficiency can cause hair loss and brittle nails. The claims supporting better hair and nail health from biotin supplements are based on a few case reports and small studies. 來源↗
L5e Specialty Society (condition-mapped)
支持
PTT · Dcard · Mobile01 彙整自公開論壇討論，非統計抽樣，僅反映社群風向。
廣告 / 業配密度 極高
低中高
📍立場總覽
社群幾乎不以「核黃素缺乏症」名稱討論，多繞著口角炎/嘴破與「吃B群」打轉，迷思多、業配密集；少有人真把它當缺乏症補B2。
💬社群實感
無共識（多數討論是口角炎/嘴破補B群，少有針對核黃素缺乏症的明確心得，效果反應分歧）
破解迷思 社群最常見的 4 個誤解
✓
事實把『嘴破』當成缺B2，但口瘡性潰瘍與口角炎成因不同，補B2對一般嘴破多半無效
✓
事實以為高單位B2吞一週就能改善嘴破（營養師指為以訛傳訛）
✓
事實把尿液變黃當成『B2沒吸收/化學合成才會黃』，實際上B2本身就是黃綠色螢光，變黃屬正常
✓
事實誤以為現代人普遍缺B2，實際臨床缺乏多見於酗酒者、長期營養不良者
🩹 社群通報的副作用
- 尿液變黃（普遍提及，多認為無害）
- 空腹服用腸胃不適
🏷️ 社群熱議品牌
依論壇被提及頻率，非銷售或品質排序。
- DHC（維他命C+B2 / 維他命B群，高劑量低價常被點名）
- 萊萃美 Nature Made（Costco 綜合B/維他命）
- 善存
- 營養師輕食 B群
⚠️ 列出僅代表「TW 社群討論度高」，不代表本站推薦或背書。本站不販售任何產品、無導購連結。
- 多樣且足量的均衡飲食
- 大規模食物強化
查看 ClaimReview 結構化資料 (JSON-LD)
{
"@context": "https://schema.org",
"@type": "ClaimReview",
"url": "https://gpt-dict.com/claim/CLM-COND-micronutrient-deficiency-INT-vitamin-b2-001/",
"datePublished": "2026-06-01",
"author": {
"@type": "Organization",
"name": "gpt-dict.com",
"url": "https://gpt-dict.com"
},
"claimReviewed": "維生素 B2（核黃素 / Riboflavin）能改善微量營養素缺乏（核黃素缺乏症 / Ariboflavinosis）",
"inLanguage": "zh-TW",
"itemReviewed": {
"@type": "Claim",
"appearance": []
},
"reviewRating": {
"@type": "Rating",
"ratingValue": 3,
"bestRating": 5,
"worstRating": 1,
"alternateName": "🟡 B 初步證據"
}
}